SCHEMBL1844802

SCHEMBL1844802

COc1ccc(CC(OC)c2ccc(O)cc2O)cc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 3/20 0.44
ALOX12 P18054 3/20 0.44
FOS P01100 1/20 0.41
TTR P02766 1/20 0.41
JUN P05412 1/20 0.41
NR3C1 P04150 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
MMP1 P03956 1/20 0.40
CYP3A4 P08684 1/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39
TUBB8 Q3ZCM7 1/20 0.39
TUBA3E Q6PEY2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1846272 0.81 MEN1 (0.49) CYP3A4LDHA
SCHEMBL2973201 0.75 ALOX15 (0.55) ALOX15ALOX12FOSTTRJUN
SCHEMBL29492396 0.73 TYR (0.63) CYP3A4TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL21830553 0.73 TYR (0.63) CYP3A4TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL23922715 0.72 TYR (0.54) ALOX15CYP3A4MAOB
SCHEMBL21830502 0.72 TYR (0.53) CYP3A4TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL29492464 0.72 TYR (0.54) ALOX15CYP3A4MAOB
SCHEMBL29492461 0.72 TYR (0.53) CYP3A4TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL26300965 0.72 ALOX15 (0.84) ALOX15ALOX12FOSTTRJUN
SCHEMBL263095 0.71 MAOB (0.58) ALOX15CYP3A4TUBB1MAOBESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4046619-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS Unigen, Inc. (US) 2022-08-24 EP claimed
US-8658838-B2 Series of skin whitening (lightening) compounds UNIGEN, INC. (US) 2014-02-25 US claimed
US-20130209383-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS UNIGEN, INC. (US) 2013-08-15 US claimed
US-8362305-B2 Series of skin whitening (lightening) compounds UNIGEN, INC. (US) 2013-01-29 US claimed
EP-2323612-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS Unigen, Inc. (US) 2011-05-25 EP claimed
WO-2010011630-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS UNIGEN PHARMACEUTICALS, INC. (US) 2010-01-28 WO claimed
US-20100016347-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS UNIGEN PHARMACEUTICALS, INC. (US) 2010-01-21 US claimed
US-12227472-B2 Series of skin-whitening (lightening) compounds UNIGEN, INC. (US) 2025-02-18 US disclosed
US-20230399282-A1 Series of Skin-Whitening (Lightening) Compounds UNIGEN, INC. (US) 2023-12-14 US disclosed
US-11739040-B2 Series of skin-whitening (lightening) compounds UNIGEN, INC. (US) 2023-08-29 US disclosed
EP-4046619-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS Unigen, Inc. (US) 2022-08-24 EP disclosed
EP-3542780-B1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS UNIGEN INC (US) 2022-01-19 EP disclosed
US-20210188751-A1 Series of Skin-Whitening (Lightening) Compounds UNIGEN, INC. (US) 2021-06-24 US disclosed
US-20140363388-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS UNIGEN, INC. (US) 2014-12-11 US disclosed
US-8658838-B2 Series of skin whitening (lightening) compounds UNIGEN, INC. (US) 2014-02-25 US disclosed
US-20130209383-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS UNIGEN, INC. (US) 2013-08-15 US disclosed
US-8362305-B2 Series of skin whitening (lightening) compounds UNIGEN, INC. (US) 2013-01-29 US disclosed
EP-2323612-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS Unigen, Inc. (US) 2011-05-25 EP disclosed
WO-2010011630-A1 SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS UNIGEN PHARMACEUTICALS, INC. (US) 2010-01-28 WO disclosed
US-20100016347-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS UNIGEN PHARMACEUTICALS, INC. (US) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739040-B2 Series of skin-whitening (lightening) compounds TYR, TH, MAOB ALOX15 149/4885ALOX12 162/4885FOS 2220/4885
US-20230399282-A1 Series of Skin-Whitening (Lightening) Compounds TYR, TH, MAOB ALOX15 149/4885ALOX12 162/4885FOS 2220/4885
US-20130209383-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS TYR, MAOB, TH ALOX15 146/4885ALOX12 158/4885FOS 2648/4885
US-20140363388-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS TYR, MAOB, TH ALOX15 146/4885ALOX12 158/4885FOS 2648/4885
US-20100016347-A1 SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS TYR, MAOB, TH ALOX15 146/4885ALOX12 158/4885FOS 2648/4885
US-20210188751-A1 Series of Skin-Whitening (Lightening) Compounds TYR, TH, MAOB ALOX15 149/4885ALOX12 162/4885FOS 2220/4885
US-12227472-B2 Series of skin-whitening (lightening) compounds TYR, TH, MAOB ALOX15 149/4885ALOX12 162/4885FOS 2220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.